1. Genentech wants to double its San Francisco footprint — Biotechs with the biggest cash piles — Purdue Pharma wants to pay bonuses even under bankruptcy proceedings — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

PREDICTIONS

Discussion in 'Zogenix' started by Anonymous, Feb 24, 2014 at 10:26 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Look, I'm double dipping here, so if this job doesn't work for me, not a big deal (Don't waste your time replying they will figure me out, they won't. No one has for 6 years, so bite me). Here, though, are my predictions for this job. You will argu them, but in 12 months come back to this post cause I'll be right on.

    1) Sold in 12 months. There are people who were brought to this company that specialize in just this, trying to get a big pharma company to buy. Take a look and you'll figure out quick who they are and what companies they were with, and their inevitable outcome. It's true.

    2) Mass layoffs. With all the bad press about Zohydro, states trying to stop its approval, the risk of another Oxy, C3's that are easier and cheaper to write, this product will have little to no coverage. It will be a tough sell, even for your buddy docs who carried you at other jobs. Plus, the S Pen sucks. About 50% of the time it bruises the skin and doesn't inject properly. Neuro's hate it. It's got about as much business as it will ever get.

    3) Zogenix is a block buster!!! LOL, just kidding! See prediction 1 or 2.

    The idea is great, and we all have docs who are excited about Zohydro. But the truth is coverage will be painfully tough. Read the articles online. The states, the national government and the communities don't want this. If you take it for what it is (a paycheck for a year) you will be fine. If you think you are going to cash in the stock and retire in 4 years, you are an idiot. Good luck.
     
  2. Anonymous

    Anonymous Guest

    Question. During my interview I asked the coverage of Zohydro, assuming it was '0" coverage, and was told by the Eastern Manager that 80% of lives would be covered. Is this true or was he not telling the truth?
     
  3. Anonymous

    Anonymous Guest

    Oh what a bad assumption. Some plans will have a six month Ndc block with new meds.
     
  4. Anonymous

    Anonymous Guest

    ZohydroTM ER (hydrocodone bitartrate extendedrelease)
    Pharmacy Coverage Policy
    Effective Date: February 20, 2014
    Revision Date: N/A
    Review Date: February 20, 2014
    Line of Business: Commercial, Medicare
    Policy Type: Prior Authorization
    Page: 1 of 7

    Humana's documents are updated regularly online. When printed, the version of this document becomes uncontrolled. Do
    not rely on printed copies for the most up‐to‐date version. Refer to http://apps.humana.com/tad/tad_new/home.aspx to
    verify that this is the current version before utilizing.
    Disclaimer
    Description
    Coverage Determination
    Background
    Medical Terms
    References
    Disclaimer
    State and federal law, as well as contract language, including definitions and specific inclusions/
    exclusions, take precedence over clinical policy and must be considered first in determining eligibility for coverage.
    Coverage may also differ for our Medicare and/or Medicaid members based on any applicable Centers for
    Medicare & Medicaid Services (CMS) coverage statements including National Coverage Determinations (NCD),
    Local Medical Review Policies (LMRP) and/or Local Coverage Determinations. See the CMS website at
    http://www.cms.hhs.gov/. The member's health plan benefits in effect on the date services are rendered must be
    used. Clinical policy is not intended to pre‐empt the judgment of the reviewing medical director or dictate to health
    care providers how to practice medicine. Health care providers are expected to exercise their medical judgment in
    rendering appropriate care. Clinical technology is constantly evolving, and we reserve the right to review and
    update this policy periodically. No part of this publication may be reproduced, stored in a retrieval system or
    transmitted, in any shape or form or by any means, electronic, mechanical, photocopying or otherwise without
    permission from Humana.
    Description Zohydro ER (hydrocodone bitartrate extended‐release) is a potent synthetic opioid
    pain reliever.
    This agent is a pure mu‐agonist opioid whose principal therapeutic action is analgesia.
    Zohydro ER (hydrocodone bitartrate extended‐release) is indicated for the
    management of pain severe enough to require daily, around‐the‐clock, long‐term
    opioid treatment and for which alternative treatment options are inadequate. This
    agent is not intended for use as a prn analgesic. It is formulated to deliver the opioid
    analgesic hydrocodone over twelve hours.
    Hydrocodone bitartrate extended‐release is available as Zohydro ER: 10 mg, 15 mg,
    20 mg, 30 mg, 40 mg, and 50 mg capsules.
    ZohydroTM ER (hydrocodone bitartrate extended‐release)
    Effective Date: 2/20/2014
    Revision Date: N/A
    Review Date: 2/20/2014
    Line of Business: Commercial, Medicare
    Policy Type: Prior Authorization
    Page: 2 of 7
     
  5. Anonymous

    Anonymous Guest

    Add UHC too to the pa list.
     
  6. Anonymous

    Anonymous Guest

    I know exactly who you are! You DON'T work for ZGX and your first name starts with an S! Want me to spell it out?
     
  7. Anonymous

    Anonymous Guest

    Go ahead...I dare you!
     
  8. Anonymous

    Anonymous Guest

  9. Anonymous

    Anonymous Guest

    I am not being mean but urge you people to start looking for new jobs this year. The original post and person writing is brutally honest. Check out most recent news on cafepharma main page and CNN. Not gonna be pretty.
     
  10. Anonymous

    Anonymous Guest

    The original poster is a poser. Isn't that right, old lady whose name starts with an Sh.
     
  11. Anonymous

    Anonymous Guest

    Sure! Seeing as you are wrong. 1) My name doesn't start with and S (but you have 25 more chances to get it right), 2) You have no idea, whatsoever who I am, and 3) Your scare tactics are futile.

    My name starts with a DD, as in double dip!
     
  12. Anonymous

    Anonymous Guest

    Yes, it starts with SH, as in: shhhhh, don't tell anyone I'm double dipping! Gonna get paid for doing nothing for a few months until they go belly up.... $$$ I feel like the guy in the commercial who wears the green $$$ suit and tries to get you to buy his book on how to get rich quick...
     
  13. Anonymous

    Anonymous Guest

    Double Dipping, is a reality that Pharma Companies uncertainty & lay offs have forced savvy reps to do. Just like each company has share holders that want to see long term: growth, profitability & sustainability; I'm my own share holder, looking out for the best long term strategy for my own household.
     
  14. Anonymous

    Anonymous Guest

    No sh#t, I once triple-dipped for about 6 months! Had 3 company cars to choose from each morning. It was huge money for awhile, but had to let one go as they launched a product that put me in same offices as one of my other jobs. Gotta be careful there. Always have to have each company with products that call on different specialists. No crossing paths, no problems.
     
  15. Anonymous

    Anonymous Guest

    We are in the process of calling all former Purdue, Teva, Mallinckrodt, and Endo representatives to verify employment status. Good luck to you. You will need it
     
  16. Anonymous

    Anonymous Guest

    OP here,

    Thank goodness I am still double dipping. Hate to say it, but looks like my "predictions" may come to fruition quicker than even I thought. Stock closed at $1.98 today. Ouch! Heads at corporate must be spinning. Hope some of you enjoyed the ride like me. Told you the stock options meant nothing. Layoffs soon. Start looking now or you'll be sorry. Not trying to be a jerk, but this was obvious from the start.
     
  17. Anonymous

    Anonymous Guest

    This may pose a problem :(

    http://documents.latimes.com/counties-sue-narcotics-makers/
     
  18. Anonymous

    Anonymous Guest

    When everyone else is selling, it's time to buy. I just bought ZGNX for $1.80. A bunch of it. When ZGNX gets bought out, I'll laugh all the way to the bank.
     
  19. Anonymous

    Anonymous Guest

    It closed at $1.69 today. It was just under $5 in February. Are you sure you should be laughing?
     
  20. Anonymous

    Anonymous Guest

    So glad that I didn't get this position. Sounds like you guys are having major issues. Some of the upper management was pretty awful. Not calling out names, but the short guy was a total dick. SOB coughed on me the whole interview and gave me the flu. He had his mind made up before I even left to fly to Dallas. But karma has a way of making things right. Sorry for the reps though. I meet some really great people.